Myomectomy Market Report 2025

This myomectomy market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The myomectomy market size has grown strongly in recent years. It will grow from $1.5 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the growing prevalence of uterine fibroids, increasing advancements in surgical technology, increased awareness of treatment options, rising patient demand for effective solutions, and rising improvements in healthcare infrastructure.

The myomectomy market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to a rise in the number of women seeking fertility-preserving treatments, expanding access to specialized gynecological care, increasing investment in healthcare technology innovation, the growing prevalence of uterine disorders, rise in healthcare expenditure on advanced surgical interventions. Major trends in the forecast period include minimally invasive and robotic-assisted surgical techniques, integration of artificial intelligence in surgical planning, the development of personalized treatment plans based on genetic profiling, advancements in non-invasive diagnostic tools, a rise in patient demand for fertility-preserving options, expanding global access to advanced surgical technologies, focus on patient-centered care and postoperative recovery improvements.

The growing prevalence of uterine disorders is anticipated to drive the expansion of the myomectomy market. Uterine disorders encompass a variety of conditions affecting the uterus, such as fibroids, endometriosis, and uterine cancer, which can lead to symptoms such as pain, abnormal bleeding, and infertility. The increase in uterine disorders is linked to factors such as greater awareness, delayed childbearing, hormonal imbalances, and changes in lifestyle. Myomectomy is a surgical procedure used to remove fibroids from the uterus, addressing symptoms such as pain and heavy bleeding while preserving the uterus. For example, Cancer Australia reported in January 2024 that uterine cancer led to 561 deaths in 2020, with projections indicating an increase to 667 deaths by 2022. Thus, the rising prevalence of uterine disorders is fueling growth in the myomectomy market.

The increasing demand for minimally invasive techniques is expected to drive the growth of the myomectomy market in the coming years. Minimally invasive surgeries involve using small incisions or natural body openings to access and treat internal structures, organs, or tissues, reducing trauma to the patient's body. These techniques offer medical, financial, and aesthetic advantages that appeal to both patients and healthcare providers, leading to growing demand across various medical fields. Occlusion devices, commonly used in minimally invasive procedures, are tools designed to block or close off blood vessels, ducts, or other pathways in the body, often employed in fields like interventional cardiology and radiology to treat conditions such as aneurysms, abnormal blood flow, or congenital heart defects. For example, in January 2023, Intuitive Surgical Inc., a U.S.-based company specializing in minimally invasive care products, reported that approximately 1,875,000 surgical procedures were performed with their da Vinci surgical systems in 2022, marking an 18% increase compared to 1,594,000 procedures in 2021. As a result, the rising demand for minimally invasive techniques is fueling the growth of the myomectomy devices market.

Key players in the myomectomy market are concentrating on advancing gynecologic procedures, such as the development of tissue extraction systems to enhance surgical outcomes and offer minimally invasive options. The Tissue Extraction System is designed to aid in removing large tissue specimens during minimally invasive gynecologic surgeries, including myomectomy. For instance, in November 2022, Olympus Corporation, a Japan-based manufacturer, introduced the New Gynecologic Power Morcellator. This device, part of Olympus's tissue extraction system, is tailored for advanced gynecologic procedures involving large, calcified tissue specimens. When used with the PneumoLiner containment device, it offers a minimally invasive alternative to open hysterectomy or myomectomy.

Major companies operating in the myomectomy market are AbbVie Inc., Medtronic plc, Stryker Corporation, Mayo Clinic, Boston Scientific Corporation, Johnson Hopkins Medicines, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Hologic Inc., Columbia University Irving Medical Center, CooperSurgical Inc., Teleflex Incorporated, Karl Storz SE & Co. KG, CONMED Corporation, Richard Wolf GmbH, Park Hospital, Phoenix Medical Devices, ERBE Elektromedizin GmbH, Advin Health Care, Sterling Surgicals, LiNA Medical ApS.

North America was the largest region in the myomectomy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myomectomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the myomectomy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Myomectomy is a surgical procedure aimed at removing uterine fibroids, which are benign growths, while preserving the uterus. This procedure alleviates symptoms such as heavy bleeding, pain, and pressure related to fibroids and can improve fertility. It is often recommended for women who wish to retain their uterus.

The main types of myomectomy are abdominal myomectomy, hysteroscopic myomectomy, and laparoscopic myomectomy. Abdominal myomectomy involves removing fibroids through an incision in the abdomen, typically used for large or numerous fibroids as it provides direct access to the uterus. This procedure employs various products, such as laparoscopic power morcellators, harmonic scalpels, and laparoscopic sealers. End users include hospitals and clinics, surgical centers, and medical device companies.

The myomectomy market research report is one of a series of new reports that provides myomectomy market statistics, including myomectomy industry global market size, regional shares, competitors with a myomectomy market share, detailed myomectomy market segments, market trends and opportunities, and any further data you may need to thrive in the myomectomy industry. This myomectomy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The myomectomy market consists of revenues earned by entities by providing services such as preoperative evaluation, surgical techniques, anesthesia services, and fertility counseling and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The myomectomy market also includes sales of laparoscopic suturing devices, laparoscopic power morcellators, trocars, and laparoscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.